Glipizide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Glipizide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Asthenia | 13% |
| Headache | 8.7% |
| Dizziness | 6.8% |
| Diarrhea | 5.4% |
| Nervousness | 3.6% |
| Tremor | 3.6% |
| Flatulence | 3.2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Source: FDA labeling via NIH DailyMed (set 04fad2a9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.